MURSF yields 8000.00% · JNJ yields 2.13%● Live data
📍 MURSF pulled ahead of the other in Year 1
Combined, MURSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MURSF + JNJ for your $10,000?
Murray & Roberts Holdings Limited operates as a multinational engineering and construction company. It operates through Power, Industrial & Water; Mining; Energy, Resources & Infrastructure; Corporate & Properties segments. The company provides development, engineering, procurement, construction, operations, and maintenance solutions to the power, water, oil and gas, petrochemical, resources, industrial, and transmission and distribution markets primarily in South Africa and sub-Saharan Africa. It offers services for mining platforms, including feasibility studies, specialist engineering, vertical and decline shaft construction, mine development, and specialist mining services, such as raise boring and grouting, underground construction, and material handling solutions, as well as contract mining for projects in Australia, Indonesia, Mongolia, Kazakhstan, South Africa, sub-Saharan Africa, Canada, the United States, and Mexico. The company provides engineering and contracting services for energy, and resources and infrastructure markets, such as engineering, procurement, construction, commissioning, operations, and maintenance services; and operates under the Clough brand. Murray & Roberts Holdings Limited was founded in 1902 and is headquartered in Bedfordview, South Africa.
Full MURSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.